Indivior announces $400M convertible senior notes offering due 2031; to repay term loan and repurchase up to $75M stock

Indivior Pharmaceuticals, Inc.

$400M aggregate principal amount of convertible senior notes due 2031, with initial purchasers' option for additional $60M.
Notes are senior unsecured, pay semi-annual interest, redeemable after March 20, 2029 if stock exceeds 130% of conversion price.
Net proceeds used to repay $239M term loan plus $102M cash, repurchase up to $75M of stock from note purchasers, and general corporate purposes.
Conversions settled in cash and possibly shares; noteholders can require repurchase on fundamental change.
Offering is private under Rule 144A; notes and conversion shares not registered under Securities Act.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001625297-26-000008
form_type: 8-K
ticker: INDV
cik: 0001625297
company_name: Indivior Pharmaceuticals, Inc.
filed_at: 2026-03-12T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.674121+00:00
generated_at: 2026-05-15T13:31:51.892485+00:00
sec_items: ["8.01", "9.01"]
event_type: debt
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001625297-26-000008
json_url: https://secwatch.observer/filing/0001625297-26-000008.json
markdown_url: https://secwatch.observer/filing/0001625297-26-000008.md
text_url: https://secwatch.observer/filing/0001625297-26-000008.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000008/0001625297-26-000008-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529726000008/indv-20260312.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001625297-26-000008

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.